跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
CCP-CITALOPRAM - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
CCP-CITALOPRAM
Authorized
STANDARD
CCP-CITALOPRAM
cellchem pharmaceuticals inc.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
8214bed4b8b6577c
Company
cellchem pharmaceuticals inc.
Type
Standard
Approval Details
Approval Id
8214bed4b8b6577c
Drug Approval Canada Name
CCP-CITALOPRAM
Product Name
CCP-CITALOPRAM
Status
Cancelled Post Market
Status Date
2024-01-31
Original Market Date
2017-07-24
Din
02459914
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
28:16.04.20
Atc Original
N06AB04 CITALOPRAM
Atc Name
n 06 ab 04
Aig Number
0136243001
Company Name
cellchem pharmaceuticals inc.
Company Address
UNIT 1, 30 Concourse Gate, Ottawa, Ontario, Canada, K2E 7V7
Active Ingredients
CITALOPRAM (CITALOPRAM HYDROBROMIDE)
20 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
8214bed4b8b6577c
Type
Standard
Back to Health Canada Approvals